TI
Tharimmune Inc.
🇺🇸XNAS.THARUnited StatesHealthcare
$2.05USDdown -0.05 (-2.38%)OpenEnd of day3:21 PM
Price$2.05-0.05 (-2.38%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US4327053090
- CUSIP
- 432705309
Company
- Employees
- 2
- Headquarters
- Red Bank, United States
- Website
- https://www.tharimmune.com
- CEO
- Mr. Mark Wendland
Market
- Shares outstanding
- 39.5M
- Market cap
- $81.04M
Highlights
- Market cap
- $83.01M
- EPS LTM
- -$0.91calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -2.26calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$35.92M-194.45%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$16.13M-47.94%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.